ELDAD YARON enters EVOGENE LTD. with 4.10K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/18/2026ACC: 0001178913-26-001098
Officer· Chief Financial Officer
Since Mar 2026
4.10K
Baseline shares
100% direct
4.10K
Direct ownership
1 position
75K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Ordinary shares
DirectShares owned4.10K
Total
4.10K direct4.10K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary shares | 4.10K | Direct |
| Total | 4.10K | 4.10K direct |
Derivative Holdings2
Stock Option (right to buy ordinary shares)
DirectUnderlying security
Ordinary shares
Underlying shares
60K
Shares owned
N/A
Exercise price
2.3
Expiration
—
Exercise window
—
Stock Option (right to buy ordinary shares)
DirectUnderlying security
Ordinary shares
Underlying shares
15K
Shares owned
N/A
Exercise price
12.584
Expiration
—
Exercise window
—
Total
Underlying
75K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy ordinary shares) Direct | Ordinary shares | 2.3 | — | — | 60K | N/A |
| Stock Option (right to buy ordinary shares) Direct | Ordinary shares | 12.584 | — | — | 15K | N/A |
| Total | 75K | 0.00 | ||||